C2MA: Implementation of ACT Through Facebook for Teenagers With Asthma

Sponsor
Massachusetts General Hospital (Other)
Overall Status
Completed
CT.gov ID
NCT01675921
Collaborator
(none)
120
1
2
30.9
3.9

Study Details

Study Description

Brief Summary

The investigators hypothesize that at the end of the 12-month trial, teenagers regularly self-monitoring their asthma control with ACT administered through Facebook will have improved ACT scores as compared with teenagers receiving usual care.

Condition or Disease Intervention/Treatment Phase
  • Other: Facebook group
N/A

Detailed Description

The investigators propose to administer the Asthma Control Test (ACT), a clinically validated and reliable measure of asthma control, to a pediatric pulmonary patient population, using novel channels to improve usage of the tool and health outcomes. The investigators will administer ACT to patients using Facebook to monitor asthma control and notify clinicians when there is deterioration of control.

The goal is to improve health outcomes in patients with asthma by measuring adherence to the use of monitoring tool, follow-up visits to their specialist, and hospitalization/Emergency Department (ED) visits. To achieve this, the investigators will use a novel technology platform that is simple, secure, private and easily scalable to other relevant sites and groups, without the need for additional investment. Currently, patients take the ACT survey only during their scheduled office appointments. The aim of the study is to increase the use of ACT to monitor patients who see a pediatric pulmonologist to promote regular self-monitoring.

ACT is a short symptom-based survey consisting of 5 questions, validated in English and Spanish. Participants will receive reminders on Facebook every month to login to the study website to complete the ACT survey therefore allowing patients to easily take the survey on a regular basis, and receive reminders and educational content in the media spaces they already inhabit. Participants would receive reminders and links in the same way they would receive other reminders or notifications from Facebook. The system will rate asthma control and send patients and their specialist notification of status if it reaches critical levels, defined as a score of 14 or lower on the ACT survey. This will be a system generated notification, based on a protocol developed in conjunction with the physicians at the Massachusetts General Hospital (MGH) pediatric pulmonary department.

The intervention will study the efficacy of electronic social networks in engaging teenagers in their asthma control over time, using a simple but effective symptom-based survey tool. Both patients and providers would receive notifications in case of deteriorating control, which could result in early intervention and lead to better clinical outcomes by prompting timely intervention by the clinician. The Center for Connected Health (CCH) will work with the MGH Department of Pulmonology, as well as the Pediatric Asthma group at Partners Community HealthCare Inc. (PCHI) to enroll ambulatory teenagers with asthma in the research study for one year.

120 participants will be enrolled and randomly assigned to one of two groups.

Study Design

Study Type:
Interventional
Anticipated Enrollment :
120 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
None (Open Label)
Primary Purpose:
Health Services Research
Official Title:
Implementation of ACT Through Facebook for Teenagers With Asthma
Study Start Date :
Sep 1, 2012
Actual Primary Completion Date :
Feb 1, 2015
Actual Study Completion Date :
Apr 1, 2015

Arms and Interventions

Arm Intervention/Treatment
No Intervention: Control

Participants will continue to receive medical care from their doctor as usual. Participants will have access to this study website at the start and at the end of the study.

Experimental: Facebook group

Participants will continue to receive medical care from their doctor as usual. Participants will have access to the study website at all times throughout the study. Participants will have access to the secret study group on Facebook for 12 months. Participants will take the ACT survey once a month for 12 months.

Other: Facebook group
Facebook will be used to remind participants to take the ACT survey once every month for 12 months.

Outcome Measures

Primary Outcome Measures

  1. Asthma Control Test (ACT) scores [0 to 12 months]

    Assess the effect of the Facebook intervention (also referred to as "Connect 2 My ACT" intervention on trends of ACT scores in teenagers diagnosed with asthma

Secondary Outcome Measures

  1. Emergency Department (ED) visits and Hospital Admissions [0 to 12 months]

    Compare frequency of ED and hospital admissions between the intervention and control groups

  2. Engagement [0 to 12 months]

    To assess participant engagement in the program (total number of times ACT survey taken divided by 12)

  3. Provider engagement [0 to 12 months]

    To assess provider engagement in the program (# of times reached out to patient when alerted)

  4. Patient engagement and Emergency Department (ED) visits [0 to12 months]

    To correlate participant engagement with change in ED visits and hospital admissions.

  5. Satisfaction with intervention [at 12 months]

    To assess usability and satisfaction with the Facebook study group by administering a survey at completion of study

  6. Change in knowledge about asthma [0 to12 months]

    To assess changes in level of knowledge about asthma using the Asthma Self-Management Questionnaire, a standardized and validated survey instrument

Eligibility Criteria

Criteria

Ages Eligible for Study:
14 Years to 17 Years
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • Teenagers age 14-17 years inclusive.

  • Diagnosis of asthma by a PCP or a specialist at a Partners affiliated hospital/health center.

  • Access to computer with internet.

  • Active email account

  • Fluency in English (spoken and written)

  • Be on controller medications (such as: inhaled corticosteroids, cromolyn sodium and nedocromil sodium, long-acting beta-agonists (LABAs), and methylxanthines) to control asthma and prevent symptoms from developing.

  • Have an active account on Facebook

Exclusion Criteria:
  • Disability or co-morbidity precluding regular access to the internet.

  • Cognitive impairment.

Contacts and Locations

Locations

Site City State Country Postal Code
1 Partners Center for Connected Health Boston Massachusetts United States 02114

Sponsors and Collaborators

  • Massachusetts General Hospital

Investigators

  • Principal Investigator: Kamal Jethwani, MD, MPH, Partners Healthcare, Center for Connected Health

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Joseph C. Kvedar, Dermatologist, Massachusetts General Hospital
ClinicalTrials.gov Identifier:
NCT01675921
Other Study ID Numbers:
  • 2012-P-000674/1
First Posted:
Aug 30, 2012
Last Update Posted:
Sep 1, 2020
Last Verified:
Aug 1, 2020
Keywords provided by Joseph C. Kvedar, Dermatologist, Massachusetts General Hospital
Additional relevant MeSH terms:

Study Results

No Results Posted as of Sep 1, 2020